Skip to main content

and
  1. No Access

    Article

    Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease—Perspective from the Veterans Affair Healthcare System

    Statin-associated side effects (SASEs) can limit statin adherence and present a potential barrier to optimal statin utilization. How standardized reporting of SASEs varies across medical facilities has not bee...

    **aoming Jia, Michelle T. Lee, David J. Ramsey in Cardiovascular Drugs and Therapy (2022)

  2. No Access

    Article

    Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies—a Clinical Perspective

    While low density lipoprotein cholesterol (LDL-C) remains a key contributor of atherosclerotic cardiovascular disease (ASCVD), additional risk factors identified through epidemiological and genetic studies hav...

    **aoming Jia, **g Liu, Anurag Mehta in Cardiovascular Drugs and Therapy (2021)

  3. Article

    Correction: Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder

    A Correction to this paper has been published: https://doi.org/10.1038/s41380-021-01063-8

    **aoming Jia, Fernando S. Goes, Adam E. Locke, Duncan Palmer in Molecular Psychiatry (2021)

  4. No Access

    Article

    Lens on International Clinical Supervision: Lessons Learned from a Cross-National Comparison of Supervision

    Clinical supervision is an essential mechanism for training psychologists internationally. But although it is performed globally, scholarship has primarily addressed it through the lens of Western supervision ...

    Carol Falender, Rodney Goodyear, Changming Duan in Journal of Contemporary Psychotherapy (2021)

  5. Article

    Open Access

    Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder

    Bipolar disorder (BD) is a serious mental illness with substantial common variant heritability. However, the role of rare coding variation in BD is not well established. We examined the protein-coding (exonic)...

    **aoming Jia, Fernando S. Goes, Adam E. Locke, Duncan Palmer in Molecular Psychiatry (2021)

  6. No Access

    Article

    Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis

    Data on the relationship between omega-3 fatty acid (n-3 FA) therapy with atrial fibrillation (AF) have been inconsistent. We investigate the association between n-3 FA and risk for AF by pooling data from ava...

    **aoming Jia, Feng Gao, June K. Pickett in Cardiovascular Drugs and Therapy (2021)

  7. Article

    Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well

    The review highlights selected studies related to cardiovascular disease (CVD) prevention that were presented at the 2020 European Society of Cardiology (ESC) Congress—The Digital Experience.

    **aoming Jia, Mahmoud Al Rifai, Aliza Hussain in Current Atherosclerosis Reports (2020)

  8. Article

    Letter to the Editor: Increased Circulating Angiopoietin-like Protein 8 Levels Are Associated with Thoracic Aortic Dissection and Higher Inflammatory Conditions

    **aoming Jia in Cardiovascular Drugs and Therapy (2020)

  9. Article

    Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session

    The review highlights selected studies related to cardiovascular disease (CVD) prevention that were presented at the American College of Cardiology 2020 Virtual Scientific Session (ACC.20)/World Cardiology Con...

    **aoming Jia, Mahmoud Al Rifai, **g Liu in Current Atherosclerosis Reports (2020)

  10. No Access

    Article

    Highlights from Selected Cardiovascular Disease Prevention Studies Presented at the 2019 European Society of Cardiology Congress

    This review intends to highlight selected cardiovascular disease (CVD) prevention studies presented at the 2019 European Society of Cardiology (ESC) Congress.

    **aoming Jia, Mahmoud Al Rifai, Ty J. Gluckman in Current Atherosclerosis Reports (2019)

  11. No Access

    Article

    Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session

    At the 2019 American College of Cardiology annual scientific sessions, major randomized clinical trials in cardiovascular disease (CVD) prevention were presented.

    Mahmoud Al Rifai, **aoming Jia, Mouaz H. Al-Mallah in Current Atherosclerosis Reports (2019)

  12. No Access

    Article

    The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know

    The 2018 ACC/AHA Multisociety blood cholesterol guidelines provide updated recommendations based on contemporary evidence on the management of serum cholesterol for the prevention of atherosclerotic cardiovasc...

    **aoming Jia, Mahmoud Al Rifai, Yochai Birnbaum in Current Atherosclerosis Reports (2019)

  13. No Access

    Article

    Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions

    Atrial fibrillation is a well-known risk factor for cardioembolic stroke; a number of risk stratification scoring systems have been developed to help differentiate which patients would stand to benefit from an...

    Daniel A. Hyman, Vincent Siebert, **aoming Jia in Cardiovascular Drugs and Therapy (2019)

  14. No Access

    Article

    Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials

    Omega-3 fatty acids (ω-3 FA) are among the most well-recognized health supplements but their cardiovascular benefits have long been controversial owing to inconsistent results from previous cardiovascular outc...

    **aoming Jia, Payal Kohli, Salim S. Virani in Current Atherosclerosis Reports (2019)

  15. No Access

    Article

    Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation

    We assessed whether the SGLT-2 inhibitor dapagliflozin (Dapa) attenuates the upregulation of the cardiac Na+/H+ exchanger (NHE-1) in vitro in mouse cardiofibroblasts stimulated with lipopolysaccharides (LPS) and ...

    Yumei Ye, **aoming Jia, Mandeep Bajaj, Yochai Birnbaum in Cardiovascular Drugs and Therapy (2018)

  16. No Access

    Article

    SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials

    Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been shown to exert benefit on cardiac outcomes. In this review, we provide updates on available clinical data, studies on potential mechanisms for the C...

    **aoming Jia, Paras B. Mehta, Yumei Ye, Mahboob Alam in Current Diabetes Reports (2018)

  17. No Access

    Article

    GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials

    The aim of this study is to examine the cardioprotective properties of Glucagon-like peptide-1 receptor agonist, a class of antihyperglycemic therapy, via meta-analysis of four recently published cardiovascula...

    **aoming Jia, Mahboob Alam, Yumei Ye, Mandeep Bajaj in Cardiovascular Drugs and Therapy (2018)

  18. No Access

    Chapter

    Multisystem Organ Failure Complicating Major Burns

    Since the 1970s, surgeons have been aware of the emergence of a syndrome which is characterized by significant dysfunction of more than two organ systems, subsequent to serious traumas, prolonged and extensive...

    Shiheng Liu, **aoming Jia, Zhiyong Sheng in Recent Advances in Burns and Plastic Surge… (1985)